GGrantIndex
Sort

39,280 grants matching leukemia

Impact of low IL-10 levels at birth and leukemia risk

$666,922
Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2014 · CA

Targeted Small Molecule Inhibitors for Inv(16) Leukemia

$666,852
John Hackett Bushweller · University Of Virginia · R01 · FY2023 · CA

Lab Research Training in Pediatric Oncology-Hematology

$666,679
Alan D Friedman · Johns Hopkins University · T32 · FY2025 · CA

Novel Markers for Disease Outcome in Breast Cancer

$666,640
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Clinical Program

$666,544
William George Wierda · University Of California, San Diego · P01 · FY2012 · CA

CANCER AND LEUKEMIA GROUP B

$666,421
Brigham And Women'S Hospital · U10 · FY2001 · CA

Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)

$666,402
Susan L Slager · Mayo Clinic Rochester · R01 · FY2021 · AG

Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity

$666,297
Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2023 · HL

Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL

$666,287
Peter D. Cole · Rutgers Biomedical And Health Sciences · R01 · FY2022 · CA

Prototype System for AML Digital Twins

$666,224
Vesteinn Thorsson · Institute For Systems Biology · R01 · FY2024 · CA

Experimental Therapeutics of Pediatric Hematopoietic Malignancies

$666,058
Alan S Wayne · Division Of Clinical Sciences - Nci · ZIC · FY2013 · CA

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence

$665,941
Elizabeth Bouchard · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA

Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up

$665,941
Lydia B Zablotska · University Of California, San Francisco · R01 · FY2020 · CA

Wnt signaling in hematopoietic development

$665,603
Karl H Willert · University Of California, San Diego · R01 · FY2024 · HL

Protein Tyrosine Dephosphorylation & signal Transduction

$665,593
Nicholas K Tonks · Cold Spring Harbor Laboratory · R37 · FY2007 · CA

Neural Phenotypes of Females with Autism Spectrum Disorder

$665,466
Christine Wu Nordahl · University Of California At Davis · R01 · FY2017 · MH

Integrated Systems Biology of Pediatric AML

$665,466
Jatinder K. Lamba · University Of Florida · R01 · FY2025 · CA

HOX cluster intergenic non-coding RNAs in myeloid differentiation and function

$665,449
Peter E Newburger · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · DK

Cross-species development and credentialing of pediatric AML models

$665,385
Jeffrey Alan Magee · Washington University · R01 · FY2024 · CA

Transition State Analysis of Enzymatic Reactions

$665,271
Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2010 · GM

Impact of mutational order on molecular mechanisms of oncogenesis

$665,262
Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$665,257
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2022 · CA

Lab Research Training in Pediatric Oncology-Hematology

$665,090
Alan D Friedman · Johns Hopkins University · T32 · FY2024 · CA

Pre-malignant mutation landscape and risk factors for progression to hematologic cancers

$665,071
Pinkal Desai · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML

$664,967
Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2022 · CA